Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study

Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study

Bibliographic Details
Main Authors:	Zaccardi, F, Tan, PS, Coupland, C, Shah, BR, Clift, AK, Saatci, D, Patone, M, Griffin, SJ, Dambha-Miller, H, Khunti, K, Hippisley-Cox, J
Format:	Journal article
Language:	English
Published:	Wiley 2022

Similar Items

Sickle cell disorders and severe COVID-19 outcomes: a cohort study
by: Clift, AK, et al.
Published: (2021)

Ethnic disparities in COVID-19 outcomes: a multinational cohort study of 20 million individuals from England and Canada
by: Zaccardi, F, et al.
Published: (2023)

Quantifying the association between ethnicity and COVID-19 mortality: a national cohort study protocol
by: Dambha-Miller, H, et al.
Published: (2021)

Factors influencing influenza, pneumococcal and shingles vaccine uptake and refusal in older adults: a population-based cross-sectional study in England
by: Tan, PS, et al.
Published: (2023)

Ethnic disparities in COVID-19 outcomes: a multinational cohort study of 20 million individuals from England and Canada
by: Francesco Zaccardi, et al.
Published: (2023-02-01)

Association between race and COVID-19 outcomes among 2.6 million children in England
by: Saatci, D, et al.
Published: (2021)

Factors influencing influenza, pneumococcal and shingles vaccine uptake and refusal in older adults: a population-based cross-sectional study in England
by: Francesco Zaccardi, et al.
Published: (2023-03-01)

Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections
by: Clift, AK, et al.
Published: (2022)

Preexisting neuropsychiatric conditions and associated risk of severe COVID-19 infection and other acute respiratory infections
by: Ranger, T, et al.
Published: (2022)

Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998–2017
by: Clift, AK, et al.
Published: (2021)

Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model
by: Clift, AK, et al.
Published: (2024)

Risk of thrombocytopenia and thromboembolism after Covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
by: Hippisley-Cox, J, et al.
Published: (2021)

Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population
by: Liao, W, et al.
Published: (2021)

COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults
by: Clift, AK, et al.
Published: (2020)

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
by: Tan, PS, et al.
Published: (2022)

Uptake of COVID-19 vaccination in people with blood cancer: population-level cohort study of 12 million patients in England
by: Hirst, J, et al.
Published: (2023)

Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study
by: Piernas, C, et al.
Published: (2022)

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
by: Clift, AK, et al.
Published: (2021)

COVID-19 mortality: A complex interplay of sex, gender, and ethnicity
by: Islam, N, et al.
Published: (2020)

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
by: Patone, M, et al.
Published: (2021)

Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study
by: Hippisley-Cox, J, et al.
Published: (2017)

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
by: Patone, M, et al.
Published: (2021)

Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex
by: Patone, M, et al.
Published: (2022)

Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
by: Hippisley-Cox, J, et al.
Published: (2016)

Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study
by: Hippisley-Cox, J, et al.
Published: (2017)

Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study
by: Hippisley-Cox, J, et al.
Published: (2017)

Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study
by: Hippisley-Cox, J, et al.
Published: (2023)

Association between smoking, e-cigarette use and severe COVID-19: a cohort study
by: Gao, M, et al.
Published: (2022)

Response by Mills et al regarding article, "Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex"
by: Mills, NL, et al.
Published: (2023)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
by: Hippisley-Cox, J, et al.
Published: (2017)

Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
by: Patone, M, et al.
Published: (2021)

Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
by: Coupland Carol, et al.
Published: (2010-06-01)

Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study
by: Clift, AK, et al.
Published: (2023)

Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study
by: Clift, AK, et al.
Published: (2022)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
by: Vinogradova, Y, et al.
Published: (2018)

Childhood, teenage and young adult cancer diagnosis during the first wave of the COVID-19 pandemic: a population-based observational cohort study in England
by: Saatci, D, et al.
Published: (2022)

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
by: Hippisley-Cox, J, et al.
Published: (2020)

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
by: Vinogradova, Y, et al.
Published: (2016)

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
by: Dambha-Miller, H, et al.
Published: (2022)

Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
by: Vinogradova, Y, et al.
Published: (2019)